Two Sigma Advisers
GRCL

Two Sigma Advisers’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Two Sigma Advisers’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-33,600
Closed -$337K – 2700
2023
Q4 		$337K Buy
+33,600
New +$337K ﹤0.01% 2070